Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07827859Phase 4Not yet recruiting
Phase 4, randomised, open-label trial of tiotropium in bronchial obstruction (2 arms), sponsored by General University Hospital in Prague. Primary endpoint: Absolute change from Baseline in Forced Expiratory Volume in 1 Second at 28 weeks. Planned start Nov 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07827859.